References
- Paul M, Ma JK-C. Plant-made pharmaceuticals: leading products and production platforms. Biotechnol Appl Biochem 58:58-67; PMID:21446960; http://dx.doi.org/10.1002/bab.6
- Faye L, Boulaflous A, Benchabane M, Gomord V, Michaud D. Protein modifications in the plant secretory pathway: current status and practical implications in molecular pharming. Vaccine 2005; 23:1770-8; PMID:15734039; http://dx.doi.org/10.1016/j.vaccine.2004.11.003
- Rawlings ND, Morton FR, Kok CY, Kong J, Barrett AJ. MEROPS: the peptidase database. Nucleic Acids Res 2008; 36:D320-5; PMID:17991683; http://dx.doi.org/10.1093/nar/gkm954
- Smalle J, Vierstra RD. The ubiquitin 26S proteasome proteolytic pathway. Annu Rev Plant Biol 2004; 55:555-90; PMID:15377232; http://dx.doi.org/10.1146/annurev.arplant.55.031903.141801
- Villani ME, Morgun B, Brunetti P, Marusic C, Lombardi R, Pisoni I, Bacci C, Desiderio A, Benvenuto E, Donini M. Plant pharming of a full-sized, tumour-targeting antibody using different expression strategies. Plant Biotechnol J 2009; 7:59-72; PMID:18793269; http://dx.doi.org/10.1111/j.1467-7652.2008.00371.x
- Hehle VK, Paul MJ, Drake PM, Ma JKC, van Dolleweerd CJ. Antibody degradation in tobacco plants: a predominantly apoplastic process. BMC Biotechnol 2011; 11:128; PMID:22208820; http://dx.doi.org/10.1186/1472-6750-11-128
- Sharp JM, Doran PM. Characterization of monoclonal antibody fragments produced by plant cells. Biotechnol Bioeng 2001; 73:338-46; PMID:11320504; http://dx.doi.org/10.1002/bit.1067
- De Muynck B, Navarre C, Boutry M. Production of antibodies in plants: status after twenty years. Plant Biotechnol J 2010; 8:529-63; PMID:20132515; http://dx.doi.org/10.1111/j.1467-7652.2009.00494.x
- Ramessar K, Rademacher T, Sack M, Stadlmann J, Platis D, Stiegler G, Labrou N, Altmann F, Ma J, Stöger E, et al. Cost-effective production of a vaginal protein microbicide to prevent HIV transmission. Proc Natl Acad Sci U S A 2008; 105:3727-32; PMID:18316741; http://dx.doi.org/10.1073/pnas.0708841104
- De Muynck B, Navarre C, Nizet Y, Stadlmann J, Boutry M. Different subcellular localization and glycosylation for a functional antibody expressed in Nicotiana tabacum plants and suspension cells. Transgenic Res 2009; 18:467-82; PMID:19140023; http://dx.doi.org/10.1007/s11248-008-9240-1
- Hehle VK, Lombardi R, van Dolleweerd CJ, Paul MJ, Di Micco P, Morea V, Benvenuto E, Donini M, Ma JK-C. Site-specific proteolytic degradation of IgG monoclonal antibodies expressed in tobacco plants. Plant Biotechnol J 2015; 13:235-45; PMID:25283551; http://dx.doi.org/10.1111/pbi.12266
- Di Carli M, Tanno B, Capodicasa C, Villani ME, Salzano AM, Scaloni A, Raschellà G, Benvenuto E, Donini M. Proteome changes induced by c-myb silencing in human chronic myeloid leukemia cells suggest molecular mechanisms and putative biomarkers of hematopoietic malignancies. J Proteomics 2014; 96:200-22; PMID:24220303; http://dx.doi.org/10.1016/j.jprot.2013.10.040
- Leone JW, Hampton B, Fowler E, Moyer M, Krishna RG, Chin CCQ. Removal of N-terminal blocking groups from proteins. Curr Protoc Protein Sci 2011; Chapter 11:Unit11.7; PMID:21400688
- Niemer M, Mehofer U, Torres Acosta JA, Verdianz M, Henkel T, Loos A, Strasser R, Maresch D, Rademacher T, Steinkellner H, et al. The human anti-HIV antibodies 2F5, 2G12, and PG9 differ in their susceptibility to proteolytic degradation: down-regulation of endogenous serine and cysteine proteinase activities could improve antibody production in plant-based expression platforms. Biotechnol J 2014; 9:493-500; PMID:24478053; http://dx.doi.org/10.1002/biot.201300207